913616--3/12/2010--NATIONAL_DENTEX_CORP

related topics

{product, market, service}

{competitive, industry, competition}

{debt, indebtedness, cash}

{cost, operation, labor}

{product, liability, claim}

{cost, regulation, environmental}

{personnel, key, retain}

{tax, income, asset}

{regulation, change, law}

{stock, price, share}

{acquisition, growth, future}

We operate in a highly competitive and fragmented market that is increasingly global in scope. We face increased competitive pressures from foreign-sourced products and technology-based solutions. We face increased competitive pressures from multiple location operators and the consolidation in the industry. Our failure to generate sufficient cash to meet our liquidity needs may affect our ability to service our indebtedness and grow our business. We may be more leveraged than some of our competitors, which could adversely affect our business plans. Our Senior Credit Facility contains a number of financial and other covenants that may restrict our ability to engage in some business transactions. An impairment in the carrying value of goodwill or other acquired intangibles could negatively affect our operating results and net worth. Risks associated with our strategic acquisitions could adversely affect our business. If we fail to develop new or expand existing customer relationships, our ability to grow our business will be impaired. If we cannot continue to respond to technical innovations we may not be able to compete effectively. Our failure to attract and retain qualified personnel would adversely affect our business. Our business results are adversely affected by increases in labor, benefits and related costs. Our operating results can be adversely affected by changes in the cost or availability of raw materials, particularly precious metals like gold, platinum and palladium. Compliance with changing regulation of corporate governance, public disclosure, and accounting standards may result in additional expenses and risks. We are subject to a number of continuing listing standard requirements of Nasdaq Global Market. If we fail to comply with these listing standards we may be subject to delisting. We may face increased regulatory action by, among other governmental entities, the United States Food and Drug Administration (the FDA ). Our business may be adversely affected by the actions of and risks associated with our third-party suppliers.

Full 10-K form ▸

913616--3/12/2010--NATIONAL_DENTEX_CORP_/MA/